Ligand validation:4IB4

ERM: Ergotamine

ERM is a Ligand Of Interest in 4IB4 designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
4IB4_ERM_A_2001	44%	20%	0.205	0.935	1.38	2.02	6	18	0	0	100%	1
5TUD_ERM_A_2001	47%	39%	0.222	0.964	0.74	1.61	1	8	4	0	100%	1
4NC3_ERM_A_1202	4%	20%	0.333	0.696	1.33	2.02	8	18	0	0	100%	1
6BQG_ERM_A_1201	51%	17%	0.206	0.963	1.43	2.19	5	19	0	0	100%	1
4IAR_ERM_A_2001	42%	16%	0.202	0.921	1.43	2.22	6	18	0	0	100%	1
7C61_ERM_A_2001	20%	33%	0.326	0.93	1.17	1.48	4	11	2	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.